Antineo : Triple-Negative Breast Cancer Tumour model – HCC1806

  • HCC1806 cells

Human HCC1806 cells were isolated from the mammary gland of patient with acantholytic squamous cell carcinoma.

  • Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID/CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing HCC1806 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1:(View PDF)
Tumour growth curve of the HCC1806 cells as subcutaneous tumors Mean ± SEM (n=6; take rate 100%)

Download PDF

Contact our Team to learn more

Contact